Company Encyclopedia
View More
name
Innovator IBD 50
FFTY.US
News
View More

Insider Selling: Stoke Therapeutics (NASDAQ:STOK) Insider Sells 2,006 Shares of Stock

Barry Ticho, an insider at Stoke Therapeutics, sold 2,006 shares at $29.78 each, totaling $59,738.68. This sale reduced his holdings by 10.46%. Recent trades include selling 2,014 shares at $30.65 and 5,931 shares at $25.72. Stoke Therapeutics' stock rose 3.9% to $30.96. Analysts have mixed ratings, with a consensus "Buy" and an average target price of $31.00.

Market Beat·
US
STOK
+0.29%
Market Beat·
US
STOK
+0.29%

US Stock Fund Activity List | Tesla Rises Nearly 2%, Ranks Among the Top 10 American Automotive Brands

Tesla rose nearly 2%, entering the top 10 of American automotive brands; Meta rose over 3%, and Mark Zuckerberg plans to significantly reduce the company's metaverse business resources; Micron fell over 3%, planning to stop the consumer business of its sub-brand Inphi and cease supply to the PC/DIY market

LB Select·
US
META
+3.43%
US
TSLA
+1.74%
US
MU
-3.21%
LB Select·
US
META
+3.43%
US
TSLA
+1.74%
US
MU
-3.21%

Stocks Rumble Towards All-Time High

Toronto stocks surged towards all-time highs, driven by health-care and tech sectors, with TSX rising 317.03 points. Canadian banks reported profit increases, boosting shares. Descartes and Celestica shares soared, while telecoms and utilities lagged. U.S. trade agreement uncertainty looms. IVEY PMI dropped to 48.4. Wall Street stocks were stable, anticipating a Fed rate cut. Jobless claims fell, while Salesforce and Five Below shares rose. Oil and gold prices increased.

Baystreet·
US
CLS
+4.66%
US
FIVE
+3.23%
US
DSGX
+14.36%
Baystreet·
US
CLS
+4.66%
US
FIVE
+3.23%
US
DSGX
+14.36%

VP Howell Files To Sell 1,000 Of Comfort Systems USA Inc [FIX]

Howell Laura Finley, Vice President of Comfort Systems USA Inc, filed a Form 144 with the SEC on December 4, 2025, to sell 1,000 shares of restricted stock through Stifel Nicolaus Co Inc. The sale must occur within 90 days of the filing.

Reuters·
US
FIX
+5.83%
Reuters·
US
FIX
+5.83%

Gold Fields (NYSE:GFI) Given New $64.00 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. increased Gold Fields' price target from $62.00 to $64.00, maintaining an "overweight" rating. This suggests a potential upside of 53.33% from the previous close. The stock has a consensus rating of "Moderate Buy" with a consensus price target of $42.13. Gold Fields' shares rose 0.9% to $41.74, with institutional investors adjusting their stakes.

Market Beat·
US
GFI
+1.91%
Market Beat·
US
GFI
+1.91%
© 2025 Longbridge｜Disclaimer